Whole-grain rye intake has been suggested to have anti-cancer effect, including changes in serum hormones and reduced prostate specific antigen (PSA) in animals and humans. In this study, we investigated the effect of high intake of whole-grain rye bread on prostate cancer progression as assessed by PSA concentration in men diagnosed with prostate cancer. Fifteen men with prostate cancer who did not receive prior therapy were randomised and given a daily supplement of 250 g refined wheat bread for two weeks and, afterwards, 250 g whole-grain rye bread for six weeks. Blood samples were taken from fasting men at baseline and after two and six weeks to measure the PSA and sex hormones. The dietary intake was: energy intake 3452 kcal; protein intake 166 g, carbohydrate intake 334 g, fat 149 g, saturated fat intake 52 g, and fibre intake 40 g. Plasma total PSA, free PSE, testosterone concentrations and free androgen index tended to be higher after refined white bread treatment and lower after whole-grain rye treatment. However, none of the differences were statistically significant. There were no significant changes in sex hormone binding globulin, luteinising hormone, and follicle stimulating hormone. In this intervention trial, whole-grain rye consumption did not result in significant changes in PSA and sex hormones, which may be related to high fat intake. Further prospective trials are indicated to evaluate the potential of whole-grain rye bread, taking into account other factors.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Adlercreutz H (2002). Phyto-oestrogens and cancer. Lancet Oncol. 3 (6) 364-373.
Adlercreutz H. (2007). Lignans and human health. Crit. Rev. Clin. Lab. Sci. 44 (5-6) 483-525.
Adlercreutz H. (2010). Can rye intake decrease risk of human breast cancer? Food Nutr. Res. 54 doi: 10.3402/fnr.v54i0.5231.
Anonymous (2007). Food Nutrition Physical Activity and the Preventionof Cancer: A Global Perspective. World Cancer Research Fund. Washington DC: AICR. 537 pp.
Bach Knudsen K. E. Serena A. Kjaer A. K. J¸rgensen H. Engberg R. butyrate but not the plasma concentrations of glucose and insulin in pigs. J. Nutr. 135 (7) 1696-1704.
Beyer-Sehlmeyer G. Glei M. Hartmann E. Hughes R. Persin C. Böhm V. Rowland I. Schubert R. Jahreis G. Pool-Zobel B. L. (2003). Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Brit. J. Nutr. 90 (6) 1057-1070.
Bylund A. Zhang J. X. Bergh A. Damber J. E. Widmark A. Johansson A. Adlercreutz H. Aman P. Shepherd M. J. Hallmans G. (2000). Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate42 (4) 304-314.
Bylund A. Lundin E. Zhang J. X. Nordin A. Kaaks R. Stenman U. H. Aman P. Adlercreutz H. Nilsson T. K. Hallmans G. Bergh A. Stattin P. (2003). Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur. J. Cancer. Prev. 12 (5) 407-415.
Ferlay J. Shin H. R. Bray F. Forman D. Mathers C. Parkin D. M. (eds.). GLOBOCAN 2008 v2.0 Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr (last accessed on 15 August 2012).
Hedelin M. Klint A. Chang E. T. Bellocco R. Johansson J.-E. Andersson S.-O. Heinonen S.-M. Adlercreutz H. Adami H.-O. Grönberg H. Bälter K.A. (2006). Dietary phytoestrogen serum enterolactone and risk of prostate cancer: The cancer prostate Sweden study (Sweden). Cancer Causes Control (CCC) 17 (2) 169-180.
Landberg R. Andersson S. O. Zhang J. X. Johansson J. E. Stenman U. H. Adlercreutz H. Kamal-Eldin A. Aman P. Hallmans G. (2010). Rye whole grain and bran intake compared with refined wheat decreases urinary C-peptide plasma insulin and prostate specific antigen in men with prostate cancer. J. Nutr. 140 (12) 2180-2186.
Landström M. Zhang J. X. Hallmans G. Aman P. Bergh A. Damber J. E. Mazur W. Wähäla K. Adlercreutz H. (1998). Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36 (3)151-161.
Meija L. Erdmane D. Ignace G. Siksna I. Joffe R. Lietuvietis V. Lejnieks A. (2012). Dietary fiber intake and food sources in aged men and women in Latvia. 5th International Dietary Fibre Conference 2012. Bookof Abstracts p. 65. Rome.
Milder I. E. J. Arts I. C. W. Van De Putte B. Venema D. P. Hollman P. C. H. (2005). Lignan contents of Dutch plant foods: A database including lariciresinol pinoresinol secoisolariciresinol and matairesinol. Brit. J. Nutr. 93 (3) 393-402.
Nurmi T. Mursu J. Peñalvo J. L. Poulsen H. E. Voutilainen S. (2010). Dietary intake and urinary excretion of lignans in Finnish men. Brit. J. Nutr. 103 (5) 677-685.
Park Y. Subar A. F. Hollenbeck A. Schatzkin A. (2011). Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch InternMed. 171 (12) 1061-1068.
Sandblom G. Holmberg L. Damber J. E. Hugosson J. Johansson J. E. Lundgren R. Mattsson E. Nilsson J. Varenhorst E. (2002). Prostate- specific antigen as surrogate for characterizing prostate cancer subgroups. Scand J. Urol Nephrol. 36 (2) 106-112.
Syed D. N. Khan N. Afaq F. Mukhtar H. (2007). Chemoprevention of prostate cancer through dietary agents: Progress and promise. CancerEpidemiol. Biomarkers Prev. 16 (11) 2193-2203.
Zamora-Ros R. Knaze V. Lujan-Barrosso L. Kuhnle G. Mulligan A. Touillaud M. Slimani N. Romieu I. Powell N. Tumino R. Peeters P. H. M. De Magistris S. Ricceri F. Sonested E. Drake I. Hjartaker A. Skie G. Mouw T. Wark P. A. Domaguera D. Bueno-de-Mesquigta H. B Ros M. Molina E. Sieri S. Quiros J. R. Huerta J. M. Tjonneland A. Halkjaer J. Masala G. Teucher B. Kaaks R. Travis R. C. Dilis V. Benetou V. Trichopoulou A. Amiano P. Ardanaz E. Boeing H. Forster H. Clavel-Chapelon F. Fagherazzi G. Perquier F. Johansson G. Johansson I. Cassidy A. Overvad K. Gonzales C. A. (2012). Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur. J. Clin. Nutr. 66 (8) 932-941.